Hsien, Taiwan

Yu-Ling Leu


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yu-Ling Leu: Innovator in Pharmaceutical Chemistry

Introduction

Yu-Ling Leu is a notable inventor based in Hsien, Taiwan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that have potential applications in cancer treatment. His innovative work has led to the filing of a patent that showcases his expertise and dedication to advancing medical science.

Latest Patents

Yu-Ling Leu holds a patent for "Sulfonyl-N-hydroxyguanidine derivatives." This patent describes a compound of the formula wherein X is arylene, heteroarylene, fused arylene, fused heteroarylene, or deleted; Y is sulfonyl, --O--, or deleted; R1 is aryl, heteroaryl, fused aryl, or fused heteroaryl; R2 is H, lower alkyl, lower alkoxy, halo, nitro, cyano, haloalkyl, hydroxyl, carboxyl, amido, amino, or aminoalkyl; or a salt thereof. The patent also discloses a pharmaceutical composition that contains an excipient and an effective amount of the compound, along with a method for treating cancer through the administration of this compound to patients in need.

Career Highlights

Yu-Ling Leu is associated with the Development Center for Biotechnology, where he has been instrumental in research and development efforts. His work focuses on creating innovative solutions that address critical health challenges, particularly in oncology. His patent reflects his commitment to improving patient outcomes through scientific advancements.

Collaborations

Yu-Ling Leu has collaborated with esteemed colleagues such as Ji-Wang Chern and Shan-Shue Wang. These collaborations have fostered a productive research environment, leading to significant advancements in their respective fields.

Conclusion

Yu-Ling Leu's contributions to pharmaceutical chemistry, particularly through his patent on sulfonyl-N-hydroxyguanidine derivatives, highlight his role as an innovator in cancer treatment. His work at the Development Center for Biotechnology exemplifies the impact of dedicated research on improving healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…